ACR Image Metrix™ Names Brenda K. Young The Senior Director Of Clinical Operations

Philadelphia, PA – ACR Image Metrix is pleased to announce the addition of Brenda Young to its staff as the senior director of clinical operations. Ms. Young will be based in Philadelphia, Pennsylvania, with responsibilities of managing consultants, supervising project and safety managers, and ensuring performance of clinical operations SOPs. Her client list includes major pharmaceutical clients as well as small to midsize pharmaceutical, biotechnology, device, and clinical research organization clients.

Ms. Young's background includes many years of experience at the American College of Radiology (ACR), with previous experiences as a clinical research associate, quality control auditor, regulatory affairs coordinator, and senior director of clinical trials informatics. As the senior director of clinical trials informatics, Ms. Young managed all activities related to the clinical trials management system, trained staff on the use of the system, and participated in National Cancer Institute bioinformatics initiatives.

"Brenda's experience with ACR Image Metrix is outstanding – she is such a valuable asset to our company. She will be an excellent leader as the senior director of clinical operations," said Mike Morales, vice president, general manager, ACR Image Metrix. "Her expertise and knowledge in this industry will help us succeed in the future."

"The senior director of clinical operations needs to be an individual capable of supervising multiple departments and ensuring excellent quality in everything we produce," said Dr. Bruce Hillman, chief scientific officer, ACR Image Metrix. "I am confident that Brenda will exceed our expectations and the expectations of our clients."

About ACR Image Metrix
ACR Image Metrix is headquartered in the College's Philadelphia office, alongside the ACR's clinical research division, the leading research organization in radiology for more than three decades. This division has provided administrative, data management, information technology, image archival, and statistical support for more than 500 clinical research studies.

The ACR and the American College of Radiology Imaging Network (ACRIN) have a proven history in developing trials that standardize the use of imaging technologies, image transmission and archive, and quantification of image data to reduce variability associated with these activities, reduce the size and cost of trials, and produce more reliable results.

The ACR's clinical research programs are among the largest recipients of federal medical research grants and have an established reputation for handling large-scale clinical trials involving up to 50,000 patients and some 20 million images. ACR Image Metrix will leverage the same infrastructure and expertise, but will provide support to pharmaceutical companies, biotechnology firms, and medical device manufacturers seeking Food and Drug Administration approval to bring new drugs, therapies, and medical devices to market.

Revenue from the various research projects carried out by ACR Image Metrix will be used to help fund future ACRIN, Radiation Therapy Oncology Group (RTOG), and Quality Research in Radiation Oncology (Q-RRO) studies.

SOURCE: ACR Image Metrix